How to start Nitroglycerin (NTG) injection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

How to Start Nitroglycerin (NTG) Injection

Intravenous NTG should be initiated at a rate of 10 mcg per minute through continuous infusion via nonabsorbing tubing and increased by 10 mcg per minute every 3 to 5 minutes until symptom relief or blood pressure response is noted. 1

Initial Setup and Dosing

  • Begin IV NTG at 10 mcg/min via continuous infusion using nonabsorbing tubing 1
  • Titrate upward by 10 mcg/min increments every 3-5 minutes until one of the following occurs:
    • Relief of ischemic symptoms 1
    • Desired blood pressure response 1
    • Development of side effects (headache, hypotension) 1

Titration Algorithm

  • If no response is seen at 20 mcg/min, continue with 10 mcg/min increments 1
  • At higher doses, increments of 20 mcg/min may be used 1
  • Once symptoms are relieved, no further dose increases are needed even if blood pressure hasn't changed significantly 1
  • If symptoms persist, continue increasing until blood pressure response is observed 1
  • When partial blood pressure response is observed, reduce the increment size and lengthen interval between increases 1

Maximum Dosing and Duration

  • Although no official maximum dose is established, a ceiling of 200 mcg/min is commonly used 1
  • Even prolonged infusion (2-4 weeks) at 300-400 mcg/min does not increase methemoglobin levels 1, 2
  • Tolerance typically develops after 24 hours of continuous therapy 1
  • For patients requiring NTG beyond 24 hours, periodic dose increases may be needed to maintain efficacy 1

Blood Pressure Parameters

  • Do not titrate systolic BP below 110 mmHg in previously normotensive patients 1
  • Do not reduce BP more than 25% below baseline mean arterial pressure in hypertensive patients 1
  • Avoid NTG in patients with:
    • Initial systolic BP less than 90 mmHg 1
    • BP drop of 30 mmHg or more below baseline 1
    • Marked bradycardia or tachycardia 1

Contraindications and Precautions

  • NTG is contraindicated after use of:
    • Sildenafil within previous 24 hours 1
    • Tadalafil within previous 48 hours 1
    • Vardenafil (wait until BP returns to baseline, typically 24 hours) 1
  • Phosphodiesterase inhibitors can cause profound hypotension, MI, and even death when combined with nitrates 1

Transitioning from IV to Oral/Topical NTG

  • When patients are free of ischemic symptoms for 12-24 hours, attempt to reduce IV NTG dose 1
  • Convert to oral or topical nitrates within 24 hours in stabilized patients 1
  • Use non-tolerance producing regimens (lower doses and intermittent dosing) 1
  • Discontinue IV NTG in patients who remain free of signs and symptoms of ischemia 1
  • If ischemia recurs during continuous therapy, increase dose and consider adding nitrate-free intervals 1

Managing Nitrate Tolerance

  • Tolerance to hemodynamic effects is dose and duration dependent 1
  • To minimize tolerance, use intermittent dosing schedules that provide nitrate-free intervals during each 24-hour period 3
  • For recurrent ischemia during continuous therapy, responsiveness can often be restored by increasing the dose 1

Common Side Effects

  • Headache 1
  • Hypotension 1
  • Abrupt cessation of IV NTG may cause exacerbation of ischemic changes on ECG, so use graded reduction 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

The Role of Nitroglycerin and Other Nitrogen Oxides in Cardiovascular Therapeutics.

Journal of the American College of Cardiology, 2017

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.